The new metabolic treatments for sarcopenia

Aging Clinical and Experimental Research

Volumn 25, Issue 2, 2013, Pages 119-127

  Barillaro, Christian ^a   Liperoti, Rosa ^a   Martone, Anna Maria ^a   Onder, Graziano ^a   Landi, Francesco ^a  

^a FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

Author keywords

Metabolic agents; Muscle strength; Nutrition; Sarcopenia

Indexed keywords

AGENTS AFFECTING METABOLISM; BETA HYDROXY BETA METHYLBUTYRATE; CITRULLINE MALATE; ISOFLAVONE DERIVATIVE; LEUCINE; ORNITHINE; UNCLASSIFIED DRUG; VITAMIN D;

CLINICAL STUDY; CLINICAL TRIAL (TOPIC); DRUG ACTIVITY; HUMAN; META ANALYSIS (TOPIC); RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SARCOPENIA;

ANIMALS; HUMANS; LEUCINE; SARCOPENIA; VALERATES; VITAMIN D;

EID: 84886686533     PISSN: 15940667     EISSN: 17208319     Source Type: Journal    
DOI: 10.1007/s40520-013-0030-0     Document Type: Review

References (63)

1. Cruz-Jentoft AJ, Landi F, Topinková E, Michel JP (2010) Understanding sarcopenia as a geriatric syndrome. Curr Opin Clin Nutr Metab Care 13:1-7
2. Braddy KK, Imam SN, Palla KR, Lee TA (2009) Vitamin d deficiency/insufficiency practice patterns in a veterans health administration long-term care population: a retrospective analysis. J Am Med Dir Assoc. 10:653-657
3. Morley JE, Argiles JM, Evans WJ et al (2009) Nutritional recommendations for the management of sarcopenia. J Am Med Dir Assoc. 11:391-396
4. Kung T, Springer J, Doehner W, Anker SD, von Haehling S (2010) Novel treatment approaches to cachexia and sarcopenia: highlights from the 5th Cachexia Conference. Expert Opin Investig Drugs 19:579-585
5. Rolland Y, Onder G, Morley JE, Gillette-Guyonet S, Abellan van Kan G, Vellas B (2011) Current and future pharmacologic treatment of sarcopenia. Clin Geriatr Med 27:423-447
6. Janssen HC, Samson MM, Verhaar HJ (2002) Vitamin D deficiency, muscle function, and falls in elderly people. Am J Clin Nutr 75:611-615
7. Roth SM, Zmuda JM, Cauley JA, Shea PR, Ferrell RE (2004) Vitamin D receptor genotype is associated with fat-free mass and sarcopenia in elderly men. J Gerontol A Biol Sci Med Sci 59(1):10-15
8. Hamilton B (2010) Vitamin D and human skeletal muscle. Scand J Med Sci Sports 20:182-190
9. Nguyen TM, Lieberherr M, Fritsch J et al (2004) The rapid effects of 1,25-dihydroxyvitamin D3 require the vitamin D receptor and influence 24-hydroxylase activity: studies in human skin fibroblasts bearing vitamin D receptor mutations. J Biol Chem 279:7591-7597
10. Schleithoff SS, Zittermann A, Tenderich G et al (2006) Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr 83:754-759
11. Scott D, Blizzard L, Fell J, Ding C, Winzenberg T, Jones G (2010) A prospective study of the associations between 25-hydroxy-vitamin D, sarcopenia progression and physical activity in older adults. Clin Endocrinol 73(5):581-587
12. Sato Y, Iwamoto J, Kanoko T, Satoh K (2005) Low-dose vitamin D prevents muscular atrophy and reduces falls and hip fractures in women after stroke: a randomized controlled trial. Cerebrovasc Dis. 20:187-192
13. Annweiler C, Schott AM, Berrut G et al (2009) Vitamin D related changes in physical performance: a systematic review. J Nutr Health Aging 13:893-898
14. Kim MK, Baek KH, Song KH, Kang MI, Park CY, Lee WY, Oh KW (2011) Vitamin D deficiency is associated with sarcopenia in older Koreans, regardless of obesity: the fourth Korea national health and nutrition examination surveys (KNHANES IV) 2009. J Clin Endocrinol Metab
15. Visser M, Deeg DJH, Lips P (2003) Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam. J Clin Endocrinol Metab 88:5766-5772
16. Burton LA, Sumukadas D (2010) Optimal management of sarcopenia. Clin Interv Aging 5:217-228
17. Bischoff HA, Stahelin HB, Dick W et al (2003) Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial. J Bone Miner Res 18:343-351
18. Pfeifer M, Begerow B, Minne HW, Suppan K, Fahrleitner-Pammer A, Dobnig H (2009) Effects of a long-term vitamin D and calcium supplementation on falls and parameters of muscle function in community-dwelling older individuals. Osteoporos Int 20:315-322
19. Moreira-Pfrimer LD, Pedrosa MA, Teixeira L, Lazaretti-Castro M (2009) Treatment of vitamin D deficiency increases lower limb muscle strength in institutionalized older people independently of regular physical activity: a randomized double-blind controlled trial. Ann Nutr Metab 54:291-300
20. Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB et al (2009) Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ 339:b3692
21. Verschueren SM, Bogaerts A, Delecluse C, Claessens AL, Haentjens P, Vanderschueren D, Boonen S (2011) The effects of whole-body vibration training and vitamin D supplementation on muscle strength, muscle mass, and bone density in institutionalized elderly women: a 6-month randomized, controlled trial. J Bone Miner Res 26:42-49
22. Landi F, Liperoti R, Fusco D, Mastropaolo S, Quattrociocchi D, Proia A, Russo A, Bernabei R, Onder G (2011) Prevalence and risk factors of sarcopenia among nursing home older residents. J Gerontol A Biol Sci Med Sci
23. Annweiler C, Schott AM, Berrut G et al (2010) Vitamin D and ageing: neurological issues. Neuropsychobiology 62:139-150
24. Buell JS, Dawson-Hughes B (2008) Vitamin D and neurocognitive dysfunction: preventing decline? Mol Aspects Med 29:415-422
25. Sanders KM, Stuart AL, Williamson EJ et al (2010) Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA 303:1815-1822
26. Paddon-Jones D, Rasmussen B (2009) Dietary protein recommendations and the prevention of sarcopenia: protein, amino acid metabolism and therapy. Curr Opin Clin Nutr Metab Care 12:86-90
27. Van Loon LJ (2007) Aminoacid as pharmaconutrients for the treatment of type 2 diabetes. Immunol Endocr Metab Agents med Chem 7:39-48
28. Findla GM, Yan L, Procter J, Mieulet V, Lamb RF (2007) A MAP4 kinase related to ste20 is a nutrient sensitive regulator of mTOR signaling. Biochem J 403:13-20
29. Croizer SJ, Kimball SR, Emmert SW, Anthony JC, Jefferson LS (2005) Oral leucine administration stimulates protein synthesis in rat skeletal muscle. J Nutr 135:376-382
30. Rieu I, Sornet C, Bayle G et al (2003) Leucine-supplemented meal feeding for ten days beneficially affects postprandial muscle protein synthesis in old rats. J Nutr 133:1198-1205
31. Louard RJ, Barret EJ, Gelfand RA (1990) Effect of infused branched-chain amino acids on muscle and whole-body amino acid metabolism in man. Clin Sci 79:457-466
32. Nair KS, Schwartz RG, Welle S (1992) Leucine as a regulator of whole body and skeletal muscle protein metabolism in humans. Am J Physiol 263:E928-E934
33. Bennet WM, Connacher AA, Scrimgeour CM, Smith K, Rennie MJ (1989) Increase in anterior tibialis muscle protein synthesis in healthy man during mixed amino acid infusion: studies of incorporation of [1-13c] leucine. Clin Sci 76:447-454
34. Smith K, Barua JM, Watt PW, Scrimgeour CM, Rennie MJ (1992) Flooding with l-[1-13C]leucine stimulates human muscle protein incorporation of continuously infused l-[1-13C]valine. Am J Physiol 262:E372-E376
35. Volpi E, Mittendorfer B, Wolf SE, Wolf RR (1999) Oral amino acids stimulate muscle protein anabolism in elderly despite higher first pass splanchnic extraction. Am J Physiol 277:E513-E520
36. Volpi E, Kobayashi H, Sheffield-Moore M, Mittendorfer B, Wolfe RR (2003) Essential amino acids are primarily responsible for the amino acids stimulation of muscle protein anabolism in the healthy elderly adults. Am J Clin Nutr 78:250-258
37. Paddon-Jones D, Sheffield-Moore M, Zhang XJ, et al (2008) Amino acid ingestion improves muscle protein synthesis in the young and elderly. Am J Physiol Endocrinol Metab 286:E321-E328
38. Katsanos CS, Kobayashi H, Sheffield-Moore M, Aarsland A, Wolfe RR (2005) Aging is associated with diminished accretion of muscle proteins after the ingestion of a small bolus of essential amino acids. Am J Clin Nutr 82:1065-1073
39. Katsanos CS, Kobayashi H, Sheffield-Moore M, Aarsland A, Wolfe RR (2006) A high proportion of leucine is required for optimal stimulation of the rate of muscle protein synthesis by essential amino acids in the erderly. Am J Physiol Endocrinol Metab 291:E381-E387
40. Nissen SL, Abumrad NN (1997) Nutritional role of the leucine metabolite β-hydroxy β-methylbutyrate (HMB). J Nutr Biochem 8:300-311
41. Eley HL, Russell ST, Tisdale MJ (2008) Attenuation of depression of muscle protein synthesis induced by lipopolysaccharide, tumor necrosis factor, and angiotensin II by β-hydroxy-β-methylbutyrate. Am J Physiol Endocrinol Metab. 295:E1409-E1416
42. Eley HL, Russell ST, Tisdale MJ (2008) Mechanism of attenuation of muscle protein degradation induced by tumor necrosis factor-a and angiotensin II by β-hydroxy-β-methylbutyrate. Am J Physiol Endocrinol Metab 295:E1417-E1426
43. Eley HL, Russell ST, Baxter JH, Mukerji P, Tisdale MJ (2007) Signaling pathways initiated by β-hydroxy-β-methylbutyrate to attenuate the depression of protein synthesis in skeletal muscle in response to cachectic stimuli. Am J Physiol Endocrinol Metab 293:E923-E931
44. Manzano M, Giron MD, Salto R, Sevillano N, Rueda R, Lopez-Pedrosa JM (2009) Is β-hydroxy-β-methylbutyrate (HMB) the bioactive metabolite of l-leucine (LEU) in muscle? Molecular evidence and potential implications. Abstract presented at: European Society for Clinical Nutrition and Metabolism 31st Congress; Vienna, Austria (Abstract P267)
45. Paddon-Jones D, Short KR, Campbell WW, Volpi E, Wolfe RR (2008) Role of dietary protein in the sarcopenia of aging. Am J Clin Nutr 87(suppl):1562S-1566S
46. Flakoll P, Sharp R, Baier S, Levenhagen D, Carr C, Nissen S (2004) Effect of β-hydroxy-β-methylbutyrate, arginine, and lysine supplementation on strength, functionality, body composition, and protein metabolism in elderly women. Nutrition 20:445-451
47. Vukovich MD, Stubbs NB, Bohlken RM (2001) Body composition in 70-year old adults responds to dietary β-hydroxy-β-methylbutyrate similarly to that of young adults. J Nutr 131:2049-2052
48. Clark RH, Feleke G, Din M et al (2000) Nutritional treatment for acquired immunodeficiency virus-associated wasting using β-hydroxy β-methybutyrate, glutamine, and arginine: a randomised, double-blind, placebo controlled study. J Parenter Enteral Nutr 24:133-139
49. May PE, Barber A, D'Olimpio JT, Hourihane A, Abumrad NN (2002) Reversal of cancer-related wasting using oral supplementation with a combination of β-hydroxy-β-methylbutyrate, arginine, and glutamine. Am J Surg 183:471-479
50. Hsieh LC, Chien SL, Huang MS, Tseng HF, Chang CK (2006) Anti-inflammatory and anticatabolic effects of short-term β-hydroxy-β-methylbutyrate supplementation on chronic obstructive pulmonary disease patients in intensive care unit. Asia Pac J Clin Nutr. 15:544-550
51. Pe'rez-Guisado J, Jakeman PM (2010) Citrulline malate enhances athletic anaerobic performance and relieves muscle soreness. J Strength Cond Res 24(5):1215-1222
52. Callis A, Magnan de Bornier B, Serrano JJ, Bellet H, Saumade R (1991) Activity of citrulline malate on acid-base balance and blood ammonia and amino acid levels. Study in the animal and in man. Arzneimittelforschung 41(6):660-663
53. Bendahan D, Mattei JP, Ghattas B, Confort-Gouny S, Le Guern ME, Cozzone PJ (2002) Citrulline/malate promotes aerobic energy production in human exercising muscle. Br J Sports Med 36:282-289
54. Vanuxem P, Vanuxem D, Fomaris E, Bernasconi P (1986) The role of lactate and ammonium in fatigue. Gazette Medicale 7:62-72
55. Petrovic V, Buzadzic B, Korac A, Vasilijevic A, Jankovic A, Micunovic K, Korac B (2008) Antioxidative defence alterations in skeletal muscle during prolonged acclimation to cold: role of l-arginine/NO-producing pathway. J Exp Biol 211:114-120
56. Walrand S (2010) Ornithine alpha-ketoglutarate: could it be a new therapeutic option for sarcopenia? J Nutr Health Aging 14(7):570-577
57. Moeller LE, Peterson CT, Hanson KB et al (2003) Isoflavone-rich soy protein prevents loss of hip lean mass but does not prevent the shift in regional fat distribution in perimenopausal women. Menopause 10(4):322-331
58. Aubertin-Leheudre M, Lord C, Khalil A, Dionne IJ (2007) Six months of isoflavone supplement increases fat-free mass in obese-sarcopenic postmenopausal women: a randomized double-blind controlled trial. Eur J Clin Nutr 61:1442-1444
59. Maesta N, Nahas EA, Nahas-Neto J et al (2007) Effects of soy protein and resistance exercise on body composition and blood lipids in postmenopausal women. Maturitas 56(4):350-358
60. Chilibeck PD, Cornish SM (2008) Effect of estrogenic compounds (estrogen or phytoestrogens) combined with exercise on bone and muscle mass in older individuals. Appl Physiol Nutr Metab 33:200-212
61. Nikawa T, Ikemoto M, Sakai T, Kano M, Kitano T, Kawahara T, Teshima S, Rokutan K, Kishi K (2002) Effects of a soy protein diet on exercise-induced muscle protein catabolism in rats. Nutrition 18:490-495
62. Candow DG, Chilibeck PD, Abeysekara S, Zello GA (2011) Short-term heavy resistance training eliminates age-related deficits in muscle mass and strength in healthy older males. J Strength Cond Res. 25:326-333
63. Onder G, Della Vedova C, Landi F (2009) Validated treatments and therapeutics prospectives regarding pharmacological products for sarcopenia. J Nutr Health Aging 13:746-756